{"id":"W2520064697","doi":"10.18632/oncotarget.12065","title":"Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers","year":2016,"lang":"en","type":"article","venue":"Oncotarget","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Erlotinib; Triple-negative breast cancer; Crizotinib; Medicine; Cancer research; EGFR inhibitors; Gefitinib; Lapatinib; Receptor tyrosine kinase; Epidermal growth factor receptor; Crosstalk; Targeted therapy; Tyrosine kinase; Breast cancer; Lung cancer; Oncology; Cancer; Internal medicine; Receptor; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001265604,0.0001292131,0.0002318888,0.00008462938,0.00007704445,0.00001660017,0.00003242585,0.00004864124,0.0003151444],"category_scores_gemma":[0.00007913161,0.00008209283,0.00003881145,0.0001523907,0.00007698267,0.0001457919,0.00001991613,0.00007265832,0.00001605139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005551057,"about_ca_system_score_gemma":0.0002497626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001175023,"about_ca_topic_score_gemma":0.0001581793,"domain_scores_codex":[0.9991367,0.00002863089,0.0001994542,0.0002508448,0.0001358408,0.0002484633],"domain_scores_gemma":[0.999543,0.0001062488,0.00006646572,0.0001012787,0.00006120702,0.000121796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007112806,0.0002353825,0.8563572,0.0001036004,0.0004370688,0.00024606,0.005356973,0.00007835119,0.1070636,0.0006120541,0.00527922,0.02351928],"study_design_scores_gemma":[0.0781569,0.002443117,0.7919399,0.003635535,0.001187419,0.0004680805,0.009246305,0.000770311,0.04768889,0.005920543,0.0566097,0.00193327],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930549,0.0008051857,0.0002737003,0.002120466,0.0001707774,0.0004027582,0.0001364705,0.00004221039,0.002993528],"genre_scores_gemma":[0.9945933,0.0001173505,0.002732619,0.00026648,0.0001263294,0.0000509935,0.0000199795,0.00001996863,0.002072945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07744561,"threshold_uncertainty_score":0.345061,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01032561367063748,"score_gpt":0.3110296367389623,"score_spread":0.3007040230683248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}